HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Phase 2 Randomized, Placebo-controlled Crossover Trial to Evaluate Safety and Efficacy of Platelet-rich Plasma Injections for Peyronie's Disease: Clinical Trial Update.

Abstract
Intralesional injection of platelet-rich plasma for Peyronie's disease appears to be safe according to early observations from an ongoing clinical trial. Efficacy data remain elusive until completion of the trial.
AuthorsKevin Y Chu, Manuel L Molina, Brian Ledesma, Isaac Zucker, Russell G Saltzman, Thomas A Masterson, Ranjith Ramasamy
JournalEuropean urology focus (Eur Urol Focus) Vol. 9 Issue 1 Pg. 11-13 (01 2023) ISSN: 2405-4569 [Electronic] Netherlands
PMID36100520 (Publication Type: Randomized Controlled Trial, Clinical Trial, Phase II, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2022 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Topics
  • Male
  • Humans
  • Penile Induration (therapy)
  • Cross-Over Studies
  • Injections, Intralesional

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: